Dose-response effect of short-term calcitriol treatment on bone and mineral metabolism in normal males

Beresford, 1986, 1,25-dihydroxyvitamin D3 and human bone-derived cells in vitro: Effects on alkaline phosphatase, type I collagen and proliferation, Endocrinology, 119, 1776, 10.1210/endo-119-4-1776 Bollerslev, 1991, Effect of a short course of 1,25-dihydroxyvitamin D3 on biochemical markers of bone remodeling in adult male volunteers, Bone, 12, 339, 10.1016/8756-3282(91)90020-J Brixen, 1990, A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers, J Bone Miner Res, 5, 609, 10.1002/jbmr.5650050610 Chan, 1986, The effect of 1,25 dihydroxycholecalciferol on parathyroid hormone secretion by monolayer cultures of bovine parathyroid cells, Calcif Tissue Int, 38, 27, 10.1007/BF02556591 Chapuy, 1992, Vitamin D3 and calcium to prevent hip fractures in the elderly women, N Engl J Med, 327, 1637, 10.1056/NEJM199212033272305 Charles, 1985, Estimation of bone turnover evaluated by 47Ca-kinetics: Efficiency of serum bone gammacarboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion, J Clin Invest, 76, 2254, 10.1172/JCI112234 Charles, 1994, Assessment of bone remodeling using biochemical indicators of type I collagen synthesis and degradation: Relation to calcium kinetics, Bone Miner, 24, 81, 10.1016/S0169-6009(08)80147-X Chen, 1983, 1 alpha, 25-dihydroxyvitamin D3 receptors in cultured rat osteoblast-like cells: Glucocorticoid treatment increases receptor content, J Biol Chem, 258, 4350, 10.1016/S0021-9258(18)32630-9 Delmas, 1985, Serum bone glaprotein compared to bone histomorphometry in endocrine disease, Bone, 6, 339, 10.1016/8756-3282(85)90326-6 Delmas, 1988, Biochemical markers of bone turnover in osteoporosis, 297 Duda, 1987, 1,25-Dihydroxyvitamin D stimulation test for osteoblast function in normal and osteoporotic postmenopausal women, J Clin Invest, 79, 1249, 10.1172/JCI112944 Eriksen, 1993, Serum markers of type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometry, J Bone Miner Res, 8, 127, 10.1002/jbmr.5650080202 Gallagher, 1990, Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol, Ann Intern Med, 113, 649, 10.7326/0003-4819-113-9-649 Geusens, 1991, Short-term course of 1,25(OH)2D3 stimulates osteoblasts but not osteoclasts in osteoporosis and osteoarthritis, Calcif Tissue Int, 49, 168, 10.1007/BF02556112 Gram, 1991, Increased serum concentrations of type I procollagen C-terminal propeptide and osteocalcin during a short course of calcitriol administration to adult male volunteers, Acta Endocrinol Copenh, 125, 609, 10.1530/acta.0.1250609 Gundberg, 1991, Acute changes in serum osteocalcin during induced hypocalcemia in humans, J Clin Endocrinol Metab, 72, 438, 10.1210/jcem-72-2-438 Hasling, 1987, Exogenous triiodothyronine activates bone remodeling, Bone, 8, 65, 10.1016/8756-3282(87)90072-X Heinegård, 1989, Macromolecules in bone matrix, Connect Tissue Res, 21, 3, 10.3109/03008208909049990 Jensen, 1990, External thoracic duct venous shunt in conscious pigs for long term studies of connective tissue metabolites in lymph, Lab Anim Sci, 40, 620 Keiding, 1974, Recommended methods for the determination of four enzymes in the blood, Scand J Clin Lab Invest, 33, 291, 10.3109/00365517409082499 Lund, 1979, Measurement of 25-dihydroxyvitamin D in serum and its relation to sunshine, age, and vitamin D intake in the Danish population, Scand J Clin Lab Invest, 392, 23, 10.3109/00365517909104935 Lund, 1979, Measurement of the circulating 1,25dihydroxyvitamin D in man. Changes in serum concentrations during treatment with 1,alfa-hydroxycholecalciferol, Acta Endocrinol Copenh, 91, 338, 10.1530/acta.0.0910338 Maierhofer, 1983, Bone resorption stimulated by elevated serum 1,25-(OH)2-vitamin D concentrations in healthy men, Kidney Int, 24, 555, 10.1038/ki.1983.193 Maierhofer, 1984, Dietary calcium and serum 1,25-(OH)2-vitamin D concentrations as determinants of calcium balance in healthy men, Kidney Int, 26, 752, 10.1038/ki.1984.212 McSheety, 1987, 1,25-dihydroxyvitamin D3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption, J Clin Invest, 80, 425, 10.1172/JCI113089 Melkko, 1990, Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen., Clin Chem, 36, 1328, 10.1093/clinchem/36.7.1328 Michaelsen, 1994 Nussbaum, 1987, A highly sensitive twosite immunoradiometric assay of parathyrin (PTH) and its clinical utility in evaluating patients with hypercalcaemia, Clin Chem, 24, 1545 Orime, 1994, Effects of 1 α-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis, Calcif Tissue Int, 54, 370, 10.1007/BF00305521 Ott, 1989, Calcitriol treatment is not effective in postmenopausal osteoporosis, Ann Intern Med, 110, 267, 10.7326/0003-4819-110-4-267 Owen, 1990, Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationship in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix, J Cell Physiol, 143, 420, 10.1002/jcp.1041430304 Papapoulos, 1987, Serum osteocalcin in Paget's disease of bone: Basal concentrations and response to bisphosphonate treatment, J Clin Endocrinol, 65, 89, 10.1210/jcem-65-1-89 Parfitt, 1990, ADFR, or coherence therapy, for osteoporosis, 315 Peacock, 1974, Action of 1alpha-hydroxy vitamin D3 on calcium absorption and bone resorption in man, Lancet, 1, 385, 10.1016/S0140-6736(74)93150-X Pedrazzoni, 1989, Involutional osteoporosis and ADFR treatment: a controlled pilot study, Curr Ther Res, 45, 188 Price, 1981, Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone, J Biol, 256, 12760 Prockop, 1979, The biosynthesis of collagen and its disorders (first of two parts), N Engl J Med, 301, 13, 10.1056/NEJM197907053010104 Prummel, 1991, The course of biochemical parameters of bone turnover during treatment with corticosteroids, J Clin Endocrinol Metab, 72, 382, 10.1210/jcem-72-2-382 Raisz, 1972, 1,25-dihydroxycholecalciferol: A potent stimulator of bone resorption in tissue culture, Science, 175, 768, 10.1126/science.175.4023.768 Reichel, 1989, The role of the vitamin D endocrine system in health and disease, N Engl J Med, 320, 980, 10.1056/NEJM198904133201506 Risteli, 1988, Rapid equilibrium radioimmunoassay for the aminoterminal propeptide of type III procollagen, Clin Chem, 34, 715, 10.1093/clinchem/34.4.715 Risteli, 1993, Radioimmunoassay for the pyridinoline cross-linked carboxyterminal telopeptide of type I collagen: A new serum marker of bone collagen degradation, Clin Chem, 39, 635, 10.1093/clinchem/39.4.635 Roodman, 1985, 1,25-dihydroxyvitamin D3 causes formation of multinucleated cells with several osteoblast characteristics in cultures of primate marrow, 82, 8213 Rosalki, 1984, Two new methods for separating and quantifying bone and liver alkaline phosphatase isoenzymes in plasma, Clin Chem, 307, 1182, 10.1093/clinchem/30.7.1182 Seino, 1987, Circulating I alpha,25-dihydroxy-vitamin D levels after a single dose of 1 alpha,25-dihydroxyvitamin D3 or 1 alpha-hydroxyvitamin D3 in normal men, Bone Miner, 2, 479 Smedsröd, 1990, Circulating C-terminal propeptide of type I procollagen is cleared via the mannose receptor in liver endothelial cells, Biochem J, 271, 345, 10.1042/bj2710345 Tilyard, 1992, Treatment of postmenopausal osteoporosis with calcitriol or calcium (see comments), N Engl J Med, 326, 357, 10.1056/NEJM199202063260601 Zerwekh, 1985, Short-term 1,25-dihydroxyvitamin D3 administration raises serum osteocalcin in patients with post-menopausal osteoporosis, J Clin Endocrinol Metab, 60, 615, 10.1210/jcem-60-3-615